evt | Article | January 2020
Lower Extremity Revascularization: Recent Past and Future Directions
Commentary on five key articles related to peripheral artery disease published over the past year, top headlines, and critical questions to be answered for the future.
By Joseph J. Ingrassia, MD; Matthew T. Finn, MD; and Sahil A. Parikh, MD
evt | News | August 27, 2019
Computational Model Suggests a New Paradigm for Accelerated Treatment Optimization With Paclitaxel Devices
August 28, 2019—CBSET announced that its scientists have published data and analyses that provide critical insights into the interplay between target anatomy and device attributes in determining balloon- and stent-based paclitaxel retention in healthy and diseased arteries.
evt | Article | June 2018
evt | News | November 5, 2019
Five-Year Results From ABSORB BTK Trial Presented
November 6, 2019—The 5-year results of the ABSORB BTK trial—a prospective, nonrandomized, single-center study evaluating a novel bioresorbable, drug-eluting scaffold for the treatment of peripheral artery disease below the knee—were presented by Ramon L. Varcoe, MBBS, MS, PhD, during a late-breaking clinical trial session at VIVA 2019, the Vascular InterVentional Advances meeting held November 4–7 in Las Vegas, Nevada. Prof. Varcoe is Associate Professor of Vascular Surgery at the University of New South Wales in Sydney, Australia.
evt | News | August 18, 2014
SCAI Expert Consensus Recommendations Address Renal Artery Stenosis
August 19, 2014—The Society for Cardiovascular Angiography and Interventions (SCAI) announced that the “SCAI Expert Consensus Statement for Renal Artery Stenting (RAS) Appropriate Use” is available online ahead of print in Catheterization and Cardiovascular Interventions. The document advises that RAS to open blockages in the kidney arteries may benefit patients who have historically been excluded from modern clinical trials.